The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH)
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …

Hematopoietic cell transplantation (HCT) is a well-established treatment to control and/or
cure many malignant and nonmalignant diseases involving the hematopoietic system and …

The relative efficacy of autologous hematopoietic cell transplant (auto-HCT) vs chimeric
antigen receptor T-cell (CAR-T) therapy in patients with diffuse large B-cell lymphoma …

Abstract Historically, Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
(ALL) has been associated with poor outcomes, and allogeneic hematopoietic cell …

Abstract Disease Overview: Epstein Barr virus-positive (EBV+) diffuse large B-cell lymphoma
(DLBCL), not otherwise specified (NOS) is an entity included in the WHO classification of …

ABSTRACT The American Society for Transplantation and Cellular Therapy (ASTCT)
published its guidelines on indications for autologous and allogeneic hematopoietic cell …

Allogeneic hematopoietic stem cell transplantation (HSCT) is the gold standard curative
therapy for infants and children with many inborn errors of immunity (IEI), but adolescents …

Hematopoietic cell transplantation (HCT) has been successfully used to treat many
malignant and nonmalignant conditions. As supportive care, donor selection, and treatment …

Several nonmalignant disorders (NMDs), either inherited or acquired, can be cured by
allogeneic hematopoietic stem cell transplantation (HSCT). Between January 2012 and April …

The role of hematopoietic cell transplantation (HCT) in the management of newly diagnosed
adult acute myeloid leukemia (AML) is reviewed and critically evaluated in this evidence …